Marks KM, Kang M, Umbleja T, Avihingsanon A, et al. Immunogenicity and Safety of Hepatitis B vaccine with a Toll-like Receptor 9 Agonist Adjuvant (HEPLISAV-B) in HBV Vaccine-naive People with HIV. Clin Infect Dis 2023 Apr 5:ciad201. doi: 10.1093.
PMID: 37017075